IO Frontiers World 2019


Mark Metzke

Dr Mark Metzke

Associate, Knobbe Martens
Mark A. Metzke has been an intellectual property attorney at Knobbe Martens since 2011. He has a client practice with a focus on patent prosecution and strategic portfolio management in the pharmaceutical and biotechnological fields.  Prior to joining the firm, Mark worked as a scientist at the Hitachi Chemical Research Center, where he performed research in the area of synthetic biomaterials. Mark earned his Ph.D. from at the University of California, Irvine, researching synthetic gene delivery vectors and biomaterials.  He earned his J.D. from UCLA Law, where he focused on intellectual property law and was the Editor-in-Chief of the Journal of Law and Technology.
  • "Great venue to solidify and harmonize on the current challenges facing this sector - in real time. The caliber of the speakers and session contents was premier. “
    Dolores Baksh
    Innovation Leader, GE Healthcare
  • “A great event to learn about the hurdles that are needed to be overcome to get through the clinic.”
    Devin Bridgen
    Scientist, strategic partnerships, SQZ Biotech
  • "It was a great opportunity to share current data and thinking about the development of therapeutics directed at modulating the immune response to cancer."
    Lance Leopold
    Vice President, Head of Oncology Development, Incyte Corporation
  • "Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field."
    Dr James Trager
    Vice President, Research & Product Development, Dendreon
  • “In the rapidly moving Advanced Therapy market, Phacilitate remains one of the premier events.”
    David James
    CEO, Scinogy